(Q42260871)

English

Comparison of the immune responses induced by soluble and particulate Plasmodium vivax circumsporozoite vaccine candidates formulated in AS01 in rhesus macaques

scientific article published on 19 October 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Comparison of the immune responses induced by soluble and particulate Plasmodium vivax circumsporozoite vaccine candidates formulated in AS01 in rhesus macaques (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Plasmodium vivax

0 references

1 reference

based on heuristic

inferred from title

Jetsumon Sattabongkot

6

object named as

Jetsumon Sattabongkot

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Christian F Ockenhouse

8

object named as

Christian F Ockenhouse

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

author name string

Yannick Vanloubbeeck

1

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Sathit Pichyangkul

2

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Babak Bayat

3

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Kosol Yongvanitchit

4

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Jason W Bennett

5

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Kurt Schaecher

7

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Joe Cohen

9

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Anjali Yadava

10

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

P. vivax vaccine study group

11

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

language of work or name

0 references

publication date

19 October 2013

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

31

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

52

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

6216-6224

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Malaria eradication back on the table

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.041

7 January 2021

Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.041

7 January 2021

Global malaria mortality between 1980 and 2010: a systematic analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.041

7 January 2021

Vivax malaria: neglected and not benign

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.041

7 January 2021

Targeting the hypnozoite reservoir of Plasmodium vivax: the hidden obstacle to malaria elimination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.041

7 January 2021

Priorities in research and development of vaccines against Plasmodium vivax malaria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.041

7 January 2021

Kinetics of mosquito-injected Plasmodium sporozoites in mice: fewer sporozoites are injected into sporozoite-immunized mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.041

7 January 2021

Monovalent fragments (Fab) of monoclonal antibodies to a sporozoite surface antigen (Pb44) protect mice against malarial infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.041

7 January 2021

Incorporation of T and B epitopes of the circumsporozoite protein in a chemically defined synthetic vaccine against malaria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.041

7 January 2021

Synthetic peptide vaccine confers protection against murine malaria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.041

7 January 2021

Randomized, double-blind, phase 2a trial of falciparum malaria vaccines RTS,S/AS01B and RTS,S/AS02A in malaria-naive adults: safety, efficacy, and immunologic associates of protection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.041

7 January 2021

Plasmodium vivax: Correlation of circumsporozoite precipitation (CSP) reaction with sporozoite-lnduced protective immunity in man

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.041

7 January 2021

Inability of Malaria Vaccine to Induce Antibodies to a Protective Epitope Within Its Sequence

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.041

7 January 2021

Induction of protective antibodies in Saimiri monkeys by immunization with a multiple antigen construct (MAC) containing the Plasmodium vivax circumsporozoite protein repeat region and a universal T helper epitope of tetanus toxin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.041

7 January 2021

A novel chimeric Plasmodium vivax circumsporozoite protein induces biologically functional antibodies that recognize both VK210 and VK247 sporozoites

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.041

7 January 2021

Process development for the production of an E. coli produced clinical grade recombinant malaria vaccine for Plasmodium vivax

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.041

7 January 2021

Evaluation of immune responses to a Plasmodium vivax CSP-based recombinant protein vaccine candidate in combination with second-generation adjuvants in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.041

7 January 2021

Enhancing humoral responses to a malaria antigen with nanoparticle vaccines that expand Tfh cells and promote germinal center induction

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.041

7 January 2021

Antigen-displaying lipid-enveloped PLGA nanoparticles as delivery agents for a Plasmodium vivax malaria vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.041

7 January 2021

Evaluation of the safety and immunogenicity in rhesus monkeys of a recombinant malaria vaccine for Plasmodium vivax with a synthetic Toll-like receptor 4 agonist formulated in an emulsion

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.041

7 January 2021

Particulate delivery systems for vaccines: what can we expect?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.041

7 January 2021

The development of the RTS,S malaria vaccine candidate: challenges and lessons

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.041

7 January 2021

Simultaneous synthesis and assembly of various hepatitis B surface proteins in Saccharomyces cerevisiae

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.041

7 January 2021

Recent clinical experience with vaccines using MPL- and QS-21-containing adjuvant systems

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.041

7 January 2021

Induction of specific immune responses against the Plasmodium vivax liver-stage via in vitro activation by dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.041

7 January 2021

Immune responses and protection of Aotus monkeys immunized with irradiated Plasmodium vivax sporozoites

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.041

7 January 2021

Safety and elicitation of humoral and cellular responses in colombian malaria-naive volunteers by a Plasmodium vivax circumsporozoite protein-derived synthetic vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.041

7 January 2021

Phase I safety and immunogenicity trial of Plasmodium vivax CS derived long synthetic peptides adjuvanted with montanide ISA 720 or montanide ISA 51

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.041

7 January 2021

Cross-species immunity following immunization with a circumsporozoite protein-based vaccine for malaria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.041

7 January 2021

Differential effector pathways regulate memory CD8 T cell immunity against Plasmodium berghei versus P. yoelii sporozoites.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.041

7 January 2021

Inhibitory effect of TNF-α on malaria pre-erythrocytic stage development: influence of host hepatocyte/parasite combinations

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.041

7 January 2021

The complexity of protective immunity against liver-stage malaria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.041

7 January 2021

Potent induction of focused Th1-type cellular and humoral immune responses by RTS,S/SBAS2, a recombinant Plasmodium falciparum malaria vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.041

7 January 2021

Protective immunity induced with the RTS,S/AS vaccine is associated with IL-2 and TNF-α producing effector and central memory CD4 T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.041

7 January 2021

Circumsporozoite-specific T cell responses in children vaccinated with RTS,S/AS01E and protection against P falciparum clinical malaria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.041

7 January 2021

A CD4(+) T-cell immune response to a conserved epitope in the circumsporozoite protein correlates with protection from natural Plasmodium falciparum infection and disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.041

7 January 2021

Protective immunity induced with malaria vaccine, RTS,S, is linked to Plasmodium falciparum circumsporozoite protein-specific CD4+ and CD8+ T cells producing IFN-gamma

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.041

7 January 2021

In vitro culture of exoerythrocytic parasites of the North Korean strain of Plasmodium vivax in hepatoma cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.10.041

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2013.10.041

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42260871&oldid=1940381624"